http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019070210-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16751aa344471bf5c75647b9b99846d0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084 |
| filingDate | 2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e7549323230444d0910489fffd1a4a |
| publicationDate | 2019-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2019070210-A1 |
| titleOfInvention | Composition and methods for conditions associated with chronic pulmonary obstructive disease |
| abstract | Embodiments of the present invention disclose a composition comprising nicotinamide adenine dinucleotide (NAD+) and optionally a nonsteroidal anti-inflammatory drug (NSAID), wherein the NAD+is in an amount effective for a condition in a mammal associated with aging. Methods of making and using the invention composition are also disclosed. |
| priorityDate | 2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.